Paclitaxel's mechanistic and clinical effects on breast cancer
Paclitaxel (PTX), the most widely used anticancer drug, is applied for the treatment of
various types of malignant diseases. Mechanisms of PTX action represent several ways in …
various types of malignant diseases. Mechanisms of PTX action represent several ways in …
Metabolic comorbidities and the association with risks of recurrent metastatic disease in breast cancer survivors
SL Anwar, R Cahyono, D Prabowo, WS Avanti… - BMC cancer, 2021 - Springer
Background Obesity and other metabolic comorbidities affect over 10% of patients with
breast cancer and are closely related with adverse outcomes. Although metabolic …
breast cancer and are closely related with adverse outcomes. Although metabolic …
Age at diagnosis predicted survival outcome of female patients with breast cancer at a tertiary hospital in Yogyakarta, Indonesia
Introduction: breast cancer is the most common cancer in women in Indonesia. Patients'
survival depends on various factors, namely patient-, tumor-, and treatment-related factors …
survival depends on various factors, namely patient-, tumor-, and treatment-related factors …
Risk factors of distant metastasis after surgery among different breast cancer subtypes: a hospital-based study in Indonesia
SL Anwar, WS Avanti, AC Nugroho, L Choridah… - World Journal of …, 2020 - Springer
Background More than one third of breast cancer patients including those that are
diagnosed in early stages will develop distant metastasis. Patterns of distant metastasis and …
diagnosed in early stages will develop distant metastasis. Patterns of distant metastasis and …
[HTML][HTML] Effects of omega-3 supplementation on ki-67 and VEGF expression levels and clinical outcomes of locally advanced breast cancer patients treated with …
D Darwito, E Dharmana, I Riwanto… - Asian Pacific Journal …, 2019 - ncbi.nlm.nih.gov
Background: Omega-3 is a polyunsaturated fatty acid with an ability to regulate cell
proliferation and apoptosis through interaction with inflammatory mediators. The potential …
proliferation and apoptosis through interaction with inflammatory mediators. The potential …
[HTML][HTML] Upregulation of circulating MiR-21 expression as a potential biomarker for therapeutic monitoring and clinical outcome in breast cancer
Background: Aberrant patterns of microRNA expression have been highlighted as a
potential clinical biomarker in breast cancer as the most frequent cancer among women that …
potential clinical biomarker in breast cancer as the most frequent cancer among women that …
[HTML][HTML] Risk factors, patterns, and distribution of bone metastases and skeletal-related events in high-risk breast cancer patients
SL Anwar, WS Avanti, EK Dwianingsih… - Asian Pacific Journal …, 2022 - ncbi.nlm.nih.gov
Background: More than a quarter of breast cancer patients are at risk to develop recurrent
metastases to the bone. Objective: This study was designed to identify risk factors and …
metastases to the bone. Objective: This study was designed to identify risk factors and …
[HTML][HTML] Luminal B is the most common intrinsic molecular subtypes of invasive ductal breast carcinoma patients in East Kalimantan, Indonesia
S Paramita, EN Raharjo, M Niasari… - Asian Pacific journal …, 2019 - ncbi.nlm.nih.gov
Objective: Breast carcinoma has no longer been considered as a single and standalone
disease. Its subtypes have been known to vary in terms of risk factors, natural histories, and …
disease. Its subtypes have been known to vary in terms of risk factors, natural histories, and …
[HTML][HTML] Pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratios as additional markers for breast cancer progression: A retrospective cohort study
SL Anwar, R Cahyono, WS Avanti, HY Budiman… - Annals of Medicine and …, 2021 - Elsevier
Background Breast cancer is the most prevalent cancer that causes significant morbidity and
loss of productivity. Around a third of all breast cancer patients are potentially develop …
loss of productivity. Around a third of all breast cancer patients are potentially develop …
[HTML][HTML] Molecular subtypes of Indonesian breast carcinomas-lack of association with patient age and tumor size
Y Rahmawati, Y Setyawati, I Widodo… - Asian Pacific journal …, 2018 - ncbi.nlm.nih.gov
Objective: Breast carcinoma (BC) is a heterogeneous disease that exhibits variation in
biological behaviour, prognosis and response to therapy. Molecular classification is …
biological behaviour, prognosis and response to therapy. Molecular classification is …